小鼠模型体液代谢组学显示核磁共振可用于诊断甲状腺激素受体α1突变
甲状腺激素抵抗α型(RTHα)由THRA基因突变引起,临床表现异质、缺乏可靠生化标志物,诊断困难。研究采用四种Thra基因移码突变杂合小鼠模型,以非靶向核磁共振(NMR)代谢组学分析尿液和血浆;多变量统计显示携带类人类突变小鼠的体液代谢谱可与对照区分,且该代谢特征随时间稳定,并与小鼠甲状腺功能减退的代谢指纹明显不同。
要点
- 基于NMR的体液代谢指纹可区分携带类人类Thra突变的小鼠与对照。
- Thra突变相关尿液和血浆代谢特征随时间稳定,且不同于甲减小鼠的代谢指纹。
- 结果为在人类中诊断RTHα提供了原理验证。
核心结论
- 基于NMR的体液代谢指纹有望用于诊断人类RTHα,研究提供了原理验证。
研究设计与样本
- 使用四种Thra基因移码突变杂合小鼠模型,其中两种接近人类突变、另两种尚未在患者中发现。
- 采用非靶向NMR代谢组学方法分析小鼠尿液和血浆样本的代谢表型。
主要发现
- 多变量统计分析显示,携带类人类突变小鼠的体液代谢谱可与对照区分。
- Thra突变相关的尿液和血浆代谢特征随时间稳定。
- 该代谢特征与小鼠甲状腺功能减退的代谢指纹明显不同。
局限性
- 结论为小鼠模型中的原理验证,尚未在人类患者中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Resistance to thyroid hormone alpha (RTHα) is a rare genetic disease due to mutations in the THRA gene, which encodes thyroid hormone receptor alpha 1 (TRα1). Since its first description in 2012, 46 cases of RTHα have been reported worldwide, corresponding to 26 different mutations of TRα1. RTHα patients share some common symptoms with hypothyroid patients, without significant reduction in thyroid hormone level. The high variability of clinical features and the absence of reliable biochemical markers make the diagnosis of this disease difficult. Some of these mutations have been recently modeled in mice. Methods: In our study, we used four different mouse models heterozygous for frameshift mutations in the Thra gene. Two of them are very close to human mutations, while the two others have not yet been found in patients. We characterized the metabolic phenotypes of urine and plasma samples collected from these four animal models using an untargeted nuclear magnetic resonance (NMR)-based metabolomic approach. Results: Multivariate statistical analysis of the metabolomic profiles shows that biofluids of mice that carry human-like mutations can be discriminated from controls. Metabolic signatures associated with Thra mutations in urine and plasma are stable over time and clearly differ from the metabolic fingerprint of hypothyroidism in the mouse. Conclusion: Our results provide a proof-of-principle that easily accessible NMR-based metabolic fingerprints of biofluids could be used to diagnose RTHα in humans.
引用
- Boumaza H, Markossian S, Busi B, et al. Metabolomic Profiling of Body Fluids in Mouse Models Demonstrates that Nuclear Magnetic Resonance Is a Putative Diagnostic Tool for the Presence of Thyroid Hormone Receptor α1 Mutations. Thyroid. 2019. PMID: 31298651. doi:10.1089/thy.2018.0730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。